Skip to main content

CORRECTION article

Front. Pharmacol., 13 September 2019
Sec. Neuropharmacology
Volume 10 - 2019 | https://doi.org/10.3389/fphar.2019.01037
This article is part of the Research Topic Neuroinflammation and its Resolution: From Molecular Mechanisms to Therapeutic Perspectives View all 23 articles

Corrigendum: Scopoletin Suppresses Activation of Dendritic Cells and Pathogenesis of Experimental Autoimmune Encephalomyelitis by Inhibiting NF-κB Signaling

This article is a correction to:

  1. Scopoletin Suppresses Activation of Dendritic Cells and Pathogenesis of Experimental Autoimmune Encephalomyelitis by Inhibiting NF-κB Signaling

    1. Read original article
Fei Zhang&#x;Fei Zhang†Yuan Zhang&#x;Yuan Zhang†Ting Yang&#x;Ting Yang†Ze-Qing YeZe-Qing YeJing TianJing TianHai-Rong FangHai-Rong FangJuan-Juan HanJuan-Juan HanZhe-Zhi Wang*Zhe-Zhi Wang*Xing Li*Xing Li*
  • National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi’an, China

A Corrigendum on
Scopoletin Suppresses Activation of Dendritic Cells and Pathogenesis of Experimental Autoimmune Encephalomyelitis by Inhibiting NF-κB Signaling

by Zhang F, Zhang Y, Yang T, Ye Z-Q, Tian J, Fang H-R, Han J-J, Wang Z-Z and Li X (2019). Front. Pharmacol.10:863. doi: 10.3389/fphar.2019.00863

In the published article, author Zhe-Zhi Wang’s identity was incorrect. Instead of “co-author,” it should be “co-corresponding author.” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: scopoletin, experimental autoimmune encephalomyelitis, multiple sclerosis, dendritic cells, NF-κB signaling

Citation: Zhang F, Zhang Y, Yang T, Ye Z-Q, Tian J, Fang H-R, Han J-J, Wang Z-Z and Li X (2019) Corrigendum: Scopoletin Suppresses Activation of Dendritic Cells and Pathogenesis of Experimental Autoimmune Encephalomyelitis by Inhibiting NF-κB Signaling. Front. Pharmacol. 10:1037. doi: 10.3389/fphar.2019.01037

Received: 13 August 2019; Accepted: 14 August 2019;
Published: 13 September 2019.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2019 Zhang, Zhang, Yang, Ye, Tian, Fang, Han, Wang and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Zhe Zhi Wang, enp3YW5nQHNubnUuZWR1LmNu; Xing Li, eGluZ2xpX3hpYW5AMTI2LmNvbQ==

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.